661 related articles for article (PubMed ID: 16753021)
1. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
2. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
4. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
Billings PC; Fiori JL; Bentwood JL; O'Connell MP; Jiao X; Nussbaum B; Caron RJ; Shore EM; Kaplan FS
J Bone Miner Res; 2008 Mar; 23(3):305-13. PubMed ID: 17967130
[TBL] [Abstract][Full Text] [Related]
6. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).
Wang H; Shore EM; Pignolo RJ; Kaplan FS
Bone; 2018 Apr; 109():218-224. PubMed ID: 29170109
[TBL] [Abstract][Full Text] [Related]
7. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H.
Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T
Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447
[TBL] [Abstract][Full Text] [Related]
10. A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways.
Zuzarte-Luís V; Montero JA; Rodriguez-León J; Merino R; Rodríguez-Rey JC; Hurlé JM
Dev Biol; 2004 Aug; 272(1):39-52. PubMed ID: 15242789
[TBL] [Abstract][Full Text] [Related]
11. HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells.
O'Connell MP; Billings PC; Fiori JL; Deirmengian G; Roach HI; Shore EM; Kaplan FS
J Cell Biochem; 2007 Dec; 102(6):1493-503. PubMed ID: 17516498
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
13. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.
Hamada S; Satoh K; Hirota M; Kimura K; Kanno A; Masamune A; Shimosegawa T
J Cell Physiol; 2007 Dec; 213(3):768-74. PubMed ID: 17516553
[TBL] [Abstract][Full Text] [Related]
15. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
17. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
Ahn J; Feldman G; Terry L; Shore EM; Kaplan FS
Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
[TBL] [Abstract][Full Text] [Related]
18. [BMP signaling and bone formation].
Katagiri T
Clin Calcium; 2012 Nov; 22(11):1677-83. PubMed ID: 23103811
[TBL] [Abstract][Full Text] [Related]
19. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation.
Dahlqvist C; Blokzijl A; Chapman G; Falk A; Dannaeus K; Ibâñez CF; Lendahl U
Development; 2003 Dec; 130(24):6089-99. PubMed ID: 14597575
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]